Delivery Order SPE2DB20D7059-SPE2DB25FGRJ4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Glatiramer 40 mg/ml syringes, valued at $5,083.61. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the agency's pharmaceutical procurement strategy through established contract vehicles....
- The Defense Logistics Agency awarded a $6,973.17 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Glatiramer 40 mg/ml syringes, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,930.01 to AmerisourceBergen Drug Corp for Glatiramer 40 mg/mL syringes. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under a larger indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,888.08, is for the delivery of Glatiramer 40 mg/mL syringes. The contract has a firm fixed price pricing type and an ultimate completion date of March 29, 2024. The award was made on March 28, 2024 and there was no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,511.18, is for the delivery of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,911.09 firm fixed-price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a medication, with an ultimate completion date of March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,930.01 and has a performance period through March 2025. The contract is for the supply of Glatiramer 40 mg/mL syringes, a medication used for the treatment of multiple sclerosis. The contract was awarded on an unrestricted basis, with no set-aside designation. Amerisourcebergen holds a...
- The Defense Logistics Agency awarded a $3,666.66 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4562084498, Glatiramer 40 mg/ml syringes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 8, 2023 under a firm fixed price arrangement. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to support military readiness by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,832.12 Firm Fixed Price delivery order is for the supply of 4560559530 units of glatiramer 40 mg/ml syringes, with a performance period ending on April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency awarded a $4,879.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40mg/mL glatiramer syringes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by August 3, 2023 to support DLA's medical supply needs. No subcontractors or set aside designations were indicated. DLA manages the global supply chain for the Department of Defense, ensuring troops have the medical...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGRJ4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Glatiramer 40 mg/ml syringes valued at $5,860.02, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 9/10/25 |